Evidence map›Paper›PMID 36896478›Full record

ArticleLeukemia & lymphoma2023

Results from a phase I study of continuous infusion cladribine, high-dose cytarabine, and mitoxantrone for relapsed/refractory high-grade myeloid neoplasms.

Noam E Kopmar, Ted Gooley, Niall Curley, Kathryn Russell, Carole Shaw, Kelda Schonhoff, John Lim, Anna B Halpern, Roland B Walter, Bart L Scott and 4 more

Open access · greenAbstract readClinical Trial, Phase ILetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia & lymphoma, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Noam E KopmarDepartment of Medicine, University of Washington, Seattle, WA, USA.
Ted GooleyPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Niall CurleyDepartment of Medicine, University of Washington, Seattle, WA, USA.
Kathryn RussellDepartment of Medicine, University of Washington, Seattle, WA, USA.
Carole ShawClinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Kelda SchonhoffDepartment of Medicine, University of Washington, Seattle, WA, USA.
John LimDepartment of Medicine, University of Washington, Seattle, WA, USA.
Anna B HalpernDepartment of Medicine, University of Washington, Seattle, WA, USA.
Roland B WalterDepartment of Medicine, University of Washington, Seattle, WA, USA.ORCID 0000-0002-9268-3341
Bart L ScottDepartment of Medicine, University of Washington, Seattle, WA, USA.
Jacob AppelbaumDepartment of Medicine, University of Washington, Seattle, WA, USA.
Paul C HendrieDepartment of Medicine, University of Washington, Seattle, WA, USA.
Elihu H EsteyDepartment of Medicine, University of Washington, Seattle, WA, USA.
Mary-Elizabeth M PercivalDepartment of Medicine, University of Washington, Seattle, WA, USA.ORCID 0000-0002-7016-951X
University of Washington · USFred Hutch Cancer Center · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
RESEARCH TRAINING IN HEMATOLOGYT32HL007093 · NHLBI · UNIVERSITY OF WASHINGTON · PI Janis L Abkowitz · 1985 to 2026
$13.9M
NCI NIH HHS P30 CA015704NHLBI NIH HHS T32 HL007093
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Myeloid, AcuteMitoxantroneAntineoplastic Combined Chemotherapy ProtocolsCladribineCytarabineHumansNeoplasm Recurrence, LocalCladribineCytarabineMitoxantrone

Identifiers

PMID36896478
PMCPMC10330652
OpenAlexW4323807515

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.